Loading organizations...
Ampersand Capital Partners is a private equity firm specializing in the healthcare and life sciences sector. It makes equity investments in growth-oriented companies, leveraging scientific, technical, and operational expertise. The firm actively partners with its portfolio to drive expansion through organic growth and strategic acquisitions within key sub-segments like laboratory products and services.
Established in 1988, Ampersand holds a long-standing position as a dedicated life sciences private equity firm. Its strategy stems from deep sector understanding, fostering founder-focused collaborations. The firm applies decades of specialized industry experience to guide leadership teams, enabling them to retain control while benefiting from strategic partnership.
Ampersand targets growth-stage life sciences businesses, collaborating with management to realize full potential. Dedicated to "Forging Leaders in Healthcare & Life Sciences," the firm nurtures innovative companies. Its vision empowers enterprises with strategic guidance, fostering sustained growth and contributing to advancements across global healthcare.
Key people at Ampersand Capital Partners.
Ampersand Capital Partners was founded in 1988 by Richard A. Charpie (Founder and Managing Partner).
Ampersand Capital Partners has 1 tracked investment across 1 company. The latest tracked deal is $30.0M Series A in Alaiko in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 18, 2022 | Alaiko | $30.0M Series A | Daniel Kirchleitner | DAN Dershem, David Anderson, Maximilian Bittner, Ampersand Capital Partners, Tiger Global |
Key people at Ampersand Capital Partners.
Ampersand Capital Partners was founded in 1988 by Richard A. Charpie (Founder and Managing Partner).